Edon Morina

emventures is a premier Growth Equity & Venture Advisory firm based in Basel Switzerland, dedicated to bridge the gap between high-potential scale ups, VCs and the capital they need to scale. We specialize in end-to-end fundraising support for scale ups, VCs and PEs, strategic positioning, operational scaling, investor deal readiness and investor relations. By combining deep investor relations across DACH and Europe with general partners and limited partners, with a hands-on advisory approach we empower founders and scale ups to navigate the complexities of fundraising optimize their equity stories, and secure funding from the right partners. Advisory also focuses on Strategy for international expansion and operational scaling for companies looking to grow sales and partnerships.

SICTIC is a Switzerland based non-profit association that connects smart money investors to innovative seed and early stage tech startups. Since 2018, SICTIC is the largest and most active business angel network in Switzerland. SICTIC itself does not invest and also does not take any commission on investments.

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.